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Abstract
The tissue glue N-butyl-2-cyanoacrylate has been successfully used in many countries for the treatment of gastric fundal
variceal bleeding. However, signiﬁcant rebleeding rates and serious complications including embolism have been reported
due to differences in injection techniques. The authors demonstrate a standardized injection technique and regimen that
ensures the success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices. This article is
part of an expert video encyclopedia.
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Technique
Standard endoscopy.
Materials
• Large-channel endoscope: Olympus GIF T 160, Olympus,
Tokyo, Japan.
• Lipiodols (Guerbert Roissy, France).
• N-butyl-2-cyanoacrylate (Histoacryls; B. Braun Dexon,
Spangenberg, Germany).
Background and Endoscopic Procedures
Gastric varices occur in 5–33% of patients with portal hyper-
tension, with a reported incidence of approximately 25% in 2
years.1 Gastric varices located in the fundus tend to cause
serious bleeding and are reported to respond less well to
endoscopic treatment. Bleeding-related mortality can be as
high as 45%.2 N-butyl-2-cyanoacrylate has been used suc-
cessfully in many countries for the treatment of fundal variceal
bleeding, with a reported initial hemostasis rate greater than
90%.3–8 The reported rate of rebleeding varies signiﬁcantly
from 0%7 to 4.4%11 to 24% to 50% in other studies.9,10 There
is also a potential risk of embolism in patients with underlying
gastrorenal or gastrocaval shunts, and other serious compli-
cations such as sepsis, ﬁstula, and adherence of the needle to
the glue within the varix have also been reported. According to
the authors, the problem with the current use of N-butyl-2-
cyanoacrylate is the lack of a universal standardized injection
technique and regimen, which may otherwise minimize
complications and decrease the rebleeding rate.3,7
Standardized injection technique and treatment regimen
have been described. During the whole procedure, wear face
shields or goggles for eye protection. Preparation of the glue
mixture is crucial. To prevent N-butyl-2-cyanoacrylate from
solidifying too quickly, dilution with Lipiodols is necessary.
However, overdilution prolongs the polymerization process
and increases the risk of embolization. In our experience, the
optimum ratio for the mixture is 0.5 ml of N-butyl-2-
cyanoacrylate to 0.8 ml of Lipiodols. The therapeutic gastro-
scope is inserted into the gastric lumen. After the scope is
positioned on the target varix, the injection catheter is ad-
vanced toward the varix to determine the best injection site.
Once the optimal injection site has been determined, keeping
the tip of the catheter close to the varix, the needle is adva-
nced to puncture the varix, and 1 ml of the N-butyl-2-
cyanoacrylate–Lipiodols mixture is injected, immediately
followed by 0.8-ml distilled water to deliver the glue from the
dead space of the catheter. The needle is withdrawn into the
catheter, the endoscopist removes the injection catheter away
from the varix, and the endoscopy assistant begins to ﬂush the
needle continuously with distilled water to keep the needle
patent for the next injection. During the injection procedure,
the endoscopist continuously insufﬂates air in order to keep
the gastric wall and any excess glue away from the tip of the
endoscope. The varix is then probed with the tip of the in-
jection needle to assess whether complete obliteration of all
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tributaries has been achieved. If the fundal varix remains soft,
the injection is repeated to achieve complete obliteration.
Incomplete obliteration of the varices at the initial treatment
session may predispose to rebleeding due to the fact that 3–4
days after injection, necrosis develops around the site of in-
jection, and rebleeding may occur from the remaining patent
varix. Endoscopy is repeated 4 days after the initial injection to
further conﬁrm complete obliteration.
Key Learning Points/Tips and Tricks
• N-butyl-2-cyanoacrylate is mixed with Lipiodols in a ratio
of 0.5 to 0.8 ml.
• Avoid injection of more than 1.0 ml of the glue mixture, as
this might increase the risk of embolization.
• Before injection, the dead space of the injection catheter is
measured so that the correct volume of distilled water is
used to deliver the glue mixture from the catheter. Usually
this is 0.8 ml.
• When the dead space of the injecting catheter is ﬂushed
with distilled water to deliver the glue mixture into the
varix, the injection of a volume of distilled water greater
than the dead space of the catheter would increase the risk
of distant embolization.
• Overenthusiastic ﬂushing of the needle with distilled water to
prevent needle clogging before the needle is withdrawn from
the varix also results in an increased risk of embolization.
• For ﬂushing the needle use distilled water. (Do not use
saline because it accelerates polymerization.)
• Avoid paravariceal injection, which may induce tissue ne-
crosis, predisposing to deep ulceration, and even perforation.
Scripted Voiceover
Time
(min:sec)
Voiceover text
0:00–0:10 How N-butyl-2-cyanoacrylate injection works for
variceal bleeding.
First, we demonstrate the principle of N-butyl-2-
cyanoacrylate injection. It is crucial to inject the
glue mixture strictly intravariceally to obturate
varices.
0:15–0:25 Here we show basic characteristics of the glue: you
see that cyanoacrylate glue is highly water soluble.
0:26–0:44 In contrast, when the glue comes in to contact with
blood, immediate polymerization and hardening
occurs.
0:45–1:14 To prevent the cyanoacrylate from solidifying too
quickly, dilution with Lipiodols is necessary. The
optimal mixture of cyanoacrylate and lipiodol is
essential to achieve optimal results and avoid
complications. We recommend mixing 0.8 ml of
Lipiodol with 0.5 ml of cyanoacrylate. During the
injection procedure, continuously insufﬂate air in
order to keep the gastric wall and any excess glue
away from the tip of the endoscope.
1:15–1:27 An injection needle of 0.8 mm diameter and 8 mm
length is used.
1:28–1:40 The treatment of acute gastric variceal bleeding with
N-butyl-2-cyanoacrylate injection. This is an acute
gastric variceal bleeding from a fundal varix.
Position the scope on the target varix, and advance
the injection catheter toward the varix to determine
the best injection site.
1:41–1:48 Now the injection needle punctures the varix.
1:49–2:09 Inject 1 ml of cyanoacrylate mixture intravariceally,
followed by 0.8 ml of distilled water, in order to
deliver the glue from the catheter. The assistant
announces the end of the injection and
simultaneously withdraws the needle into the
catheter. Now remove the injection catheter away
from the varix and the assistant begins to ﬂush the
needle continuously with distilled water to keep the
needle patent for the next injection.
2:10–2:23 Here you see the glue spilling off the rupture side.
2:24–2:43 Now retract the injection needle and catheter, and
ﬂush the needle again with distilled water.
2:44–2:53 The varix is successfully obturated.
2:54–3:06 The technique of intra-variceal injection and
assessment of variceal patency. This is another
case with gastric varices. Again, 1 ml of the
cyanoacrylate-Lipiodol mixture is injected
intravariceally. Now we use ﬂuoroscopy to
illustrate the obliteration process.
3:07–3:19 Use the catheter tip to probe the varix, here it is still
soft. This signals incomplete obliteration.
3:20–3:26 Therefore, injection is repeated.
3:27–3:33 The arrow indicates a varix that is still patent.
3:34–3:42 Now the varix is hard and complete obliteration
achieved.
3:43–4:09 Repeat intra-variceal injections with 1 ml aliquots of
the cyanoacrylate-Lipiodal mixture followed by
assessment of variceal patency until the gastric
varix is completely obturated and hardened.
Arrows indicate the patent varices.
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